Artelo Biosciences Inc

ARTL

Company Profile

  • Business description

    Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

  • Contact

    505 Lomas Santa Fe
    Suite 160
    Solana BeachCA92075
    USA

    T: +1 858 925-7049

    https://www.artelobio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    6

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,826.4015.50-0.18%
CAC 407,712.6316.360.21%
DAX 4023,960.52173.070.73%
Dow JONES (US)44,828.53344.110.77%
FTSE 1008,836.1913.280.15%
HKSE23,887.8328.23-0.12%
NASDAQ20,601.10207.971.02%
Nikkei 22539,587.68223.20-0.56%
NZX 50 Index12,764.951.65-0.01%
S&P 5006,279.3551.930.83%
S&P/ASX 2008,589.3013.70-0.16%
SSE Composite Index3,473.130.810.02%

Market Movers